Promising application of magnetic nanoparticles and electromagnetic fields in articular cartilage-related diseases: an overview
The Journal of Applied Tissue Engineering · 23.02.2021
DOI: 10.22034/jate.2021.44 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Applied Tissue Engineering, erschienen am 23.02.2021. Verfasst von Haghbin Nazarpak Masoumeh.
Abstract (Originalsprache)
Articular cartilage-related diseases are a growing problem worldwide. Although there are several therapeutic options available for these diseases, the repair of damaged articular cartilage remains an intractable issue. Therefore, a strong need exists for new approaches such as offered by tissue engineering. However, this approach is also associated with some drawbacks including poor regeneration of cultured cells. Recently, magnetic nanoparticles and electromagnetic fields (EMFs) have been suggested to influence on different cellular processes such as proliferation and differentiation and thus are able to overcome these drawbacks of tissue engineering. In this article, we review the current knowledge on the definition and characteristics of magnetic nanoparticles and EMFs. We also discuss the beneficial effects of magnetic nanoparticles and EMFs in various in vitro and in vivo studies.
Schlagwörter
Zitieren
APA
Masoumeh, H. N. (2021). Promising application of magnetic nanoparticles and electromagnetic fields in articular cartilage-related diseases: an overview. The Journal of Applied Tissue Engineering. https://doi.org/10.22034/jate.2021.44
Vancouver
Masoumeh HN. Promising application of magnetic nanoparticles and electromagnetic fields in articular cartilage-related diseases: an overview. The Journal of Applied Tissue Engineering. 2021. doi:10.22034/jate.2021.44
BibTeX
@article{Masoumeh2021,
author = {Masoumeh, Haghbin Nazarpak},
title = {Promising application of magnetic nanoparticles and electromagnetic fields in articular cartilage-related diseases: an overview},
journal = {The Journal of Applied Tissue Engineering},
year = {2021},
doi = {10.22034/jate.2021.44}
}
EUVIMED